Change in HIV-1 DNA tropism despite virological success in patients receiving an enfuvirtide-based regimen. (Q51846155)

14 April 2018

title

Change in HIV-1 DNA tropism despite virological success in patients receiving an enfuvirtide-based regimen. (English)

1 reference

14 April 2018

0 references

6

Diane Descamps

1 reference

14 April 2018

Charlotte Charpentier

1

object named as

Charlotte Charpentier

1 reference

14 April 2018

Patrick Yeni

4

object named as

Patrick Yeni

1 reference

14 April 2018

François Raffi

5

object named as

François Raffi

1 reference

14 April 2018

author name string

Véronique Joly

2

1 reference

14 April 2018

Jade Ghosn

3

1 reference

14 April 2018

Laurence Morand-Joubert

7

1 reference

14 April 2018

language of work or name

English

0 references

publication date

9 May 2014

1 reference

14 April 2018

Journal of Antimicrobial Chemotherapy

number of pages

3

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

14 April 2018

volume

69

1 reference

14 April 2018

issue

9

1 reference

14 April 2018

page(s)

2588-2590

1 reference

14 April 2018

Co-receptor switch during HAART is independent of virological success.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU155

Genotypic prediction of human immunodeficiency virus type 1 tropism by use of plasma and peripheral blood mononuclear cells in the routine clinical laboratory

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU155

Intensification of antiretroviral therapy through addition of enfuvirtide in naive HIV-1-infected patients with severe immunosuppression does not improve immunological response: results of a randomized multicenter trial (ANRS 130 Apollo)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU155

Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU155

HIV-1 coreceptor use in triple-class treatment-experienced patients: baseline prevalence, correlates, and relationship to enfuvirtide response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU155

Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU155

Dynamics of HIV tropism under suppressive antiretroviral therapy: implications for tropism testing in subjects with undetectable viraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU155

European guidelines on the clinical management of HIV-1 tropism testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU155

21 January 2018

Identifiers

DOI

10.1093/JAC/DKU155

1 reference

14 April 2018

1 reference

14 April 2018